SCHEMBL2819377

SCHEMBL2819377

CC(C)(C)OC(=O)C(C)(C)Sc1ccc(C(=O)OCc2cnn(Cc3ccc4ccccc4c3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 4/20 0.39
GPR119 Q8TDV5 1/20 0.35
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
ADRB3 P13945 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
PKM P14618 1/20 0.34
SCD O00767 1/20 0.34
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
PLA2G1B P04054 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2820791 0.91 KLKB1 (0.39) KLKB1PDE4APDE4BPDE4CPDE4D
SCHEMBL2822380 0.89 LMNA (0.41) GPR119SCDGAAKMT2AMAPT
SCHEMBL2818632 0.88 GPR119 (0.37) KLKB1GPR119PKMSCDMAPT
SCHEMBL2822756 0.87 KLKB1 (0.37) KLKB1SCDKMT2ASMN1; SMN2
SCHEMBL2819508 0.87 TSHR (0.36) KLKB1PKMKMT2ACYP1A2CYP2D6
SCHEMBL2823014 0.86 KLKB1 (0.39) KLKB1GPR119SCDGAAKMT2A
SCHEMBL2821921 0.86 THRB (0.42) MAPT
SCHEMBL2821362 0.84 RARB (0.35) GPR119PLA2G1BCYP1A2CYP3A4CYP2D6
SCHEMBL2823535 0.80 PPARG (0.44) KLKB1
SCHEMBL2821986 0.79 TBXAS1 (0.42) KLKB1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184815-A1 AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC 2010-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184815-A1 AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA PPARA, PPARD, PPARG KLKB1 1854/4885GPR119 12/4885ADRB2 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.